In experimental transplant models, a CXCR4 antagonist burixafor significantly attenuated the incidence rate of acute rejection after heart transplantation in minipigs [37] and CXCR4 antagonism inhibited the expression of profibrotic genes and attenuated renal fibrosis in rats [38]. This evidence concerns the gene CXCR4 and renal fibrosis.